Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Durvalumab market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Durvalumab market. Detailed analysis of key players, along with key growth strategies adopted by Durvalumab industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Medimmune (AstraZeneca)
By Type:
24mL Injection
10mL Injection
By End-User:
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Durvalumab Market
-
1.3 Market Segment by Type
-
1.3.1 China Durvalumab Market Size and Growth Rate of 24mL Injection from 2016 to 2027
-
1.3.2 China Durvalumab Market Size and Growth Rate of 10mL Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2016 to 2027
-
1.4.2 China Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2016 to 2027
-
1.4.3 China Durvalumab Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Durvalumab Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Durvalumab by Major Types
-
3.4.1 Market Size and Growth Rate of 24mL Injection
-
3.4.2 Market Size and Growth Rate of 10mL Injection
4 Segmentation of Durvalumab Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Durvalumab by Major End-Users
-
4.4.1 Market Size and Growth Rate of Durvalumab in Locally Advanced Urothelial Carcinoma
-
4.4.2 Market Size and Growth Rate of Durvalumab in Metastatic Urothelial Carcinoma
-
4.4.3 Market Size and Growth Rate of Durvalumab in Other
5 Market Analysis by Regions
-
5.1 China Durvalumab Production Analysis by Regions
-
5.2 China Durvalumab Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Durvalumab Landscape Analysis
-
6.1 North China Durvalumab Landscape Analysis by Major Types
-
6.2 North China Durvalumab Landscape Analysis by Major End-Users
7 Central China Durvalumab Landscape Analysis
-
7.1 Central China Durvalumab Landscape Analysis by Major Types
-
7.2 Central China Durvalumab Landscape Analysis by Major End-Users
8 South China Durvalumab Landscape Analysis
-
8.1 South China Durvalumab Landscape Analysis by Major Types
-
8.2 South China Durvalumab Landscape Analysis by Major End-Users
9 East China Durvalumab Landscape Analysis
-
9.1 East China Durvalumab Landscape Analysis by Major Types
-
9.2 East China Durvalumab Landscape Analysis by Major End-Users
10 Northeast China Durvalumab Landscape Analysis
-
10.1 Northeast China Durvalumab Landscape Analysis by Major Types
-
10.2 Northeast China Durvalumab Landscape Analysis by Major End-Users
11 Southwest China Durvalumab Landscape Analysis
-
11.1 Southwest China Durvalumab Landscape Analysis by Major Types
-
11.2 Southwest China Durvalumab Landscape Analysis by Major End-Users
12 Northwest China Durvalumab Landscape Analysis
-
12.1 Northwest China Durvalumab Landscape Analysis by Major Types
-
12.2 Northwest China Durvalumab Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Medimmune (AstraZeneca)
-
13.1.1 Medimmune (AstraZeneca) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Durvalumab Market Size and Growth Rate of 24mL Injection from 2016 to 2027
-
Figure China Durvalumab Market Size and Growth Rate of 10mL Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2016 to 2027
-
Figure China Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2016 to 2027
-
Figure China Durvalumab Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Durvalumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Durvalumab Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Durvalumab
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Durvalumab by Different Types from 2016 to 2027
-
Table Consumption Share of Durvalumab by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 24mL Injection
-
Figure Market Size and Growth Rate of 10mL Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Durvalumab by Different End-Users from 2016 to 2027
-
Table Consumption Share of Durvalumab by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma
-
Figure Market Size and Growth Rate of Metastatic Urothelial Carcinoma
-
Figure Market Size and Growth Rate of Other
-
Table China Durvalumab Production by Regions
-
Table China Durvalumab Production Share by Regions
-
Figure China Durvalumab Production Share by Regions in 2016
-
Figure China Durvalumab Production Share by Regions in 2021
-
Figure China Durvalumab Production Share by Regions in 2027
-
Table China Durvalumab Consumption by Regions
-
Table China Durvalumab Consumption Share by Regions
-
Figure China Durvalumab Consumption Share by Regions in 2016
-
Figure China Durvalumab Consumption Share by Regions in 2021
-
Figure China Durvalumab Consumption Share by Regions in 2027
-
Table North China Durvalumab Consumption by Types from 2016 to 2027
-
Table North China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure North China Durvalumab Consumption Share by Types in 2016
-
Figure North China Durvalumab Consumption Share by Types in 2021
-
Figure North China Durvalumab Consumption Share by Types in 2027
-
Table North China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table North China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure North China Durvalumab Consumption Share by End-Users in 2016
-
Figure North China Durvalumab Consumption Share by End-Users in 2021
-
Figure North China Durvalumab Consumption Share by End-Users in 2027
-
Table Central China Durvalumab Consumption by Types from 2016 to 2027
-
Table Central China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure Central China Durvalumab Consumption Share by Types in 2016
-
Figure Central China Durvalumab Consumption Share by Types in 2021
-
Figure Central China Durvalumab Consumption Share by Types in 2027
-
Table Central China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table Central China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Durvalumab Consumption Share by End-Users in 2016
-
Figure Central China Durvalumab Consumption Share by End-Users in 2021
-
Figure Central China Durvalumab Consumption Share by End-Users in 2027
-
Table South China Durvalumab Consumption by Types from 2016 to 2027
-
Table South China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure South China Durvalumab Consumption Share by Types in 2016
-
Figure South China Durvalumab Consumption Share by Types in 2021
-
Figure South China Durvalumab Consumption Share by Types in 2027
-
Table South China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table South China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure South China Durvalumab Consumption Share by End-Users in 2016
-
Figure South China Durvalumab Consumption Share by End-Users in 2021
-
Figure South China Durvalumab Consumption Share by End-Users in 2027
-
Table East China Durvalumab Consumption by Types from 2016 to 2027
-
Table East China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure East China Durvalumab Consumption Share by Types in 2016
-
Figure East China Durvalumab Consumption Share by Types in 2021
-
Figure East China Durvalumab Consumption Share by Types in 2027
-
Table East China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table East China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure East China Durvalumab Consumption Share by End-Users in 2016
-
Figure East China Durvalumab Consumption Share by End-Users in 2021
-
Figure East China Durvalumab Consumption Share by End-Users in 2027
-
Table Northeast China Durvalumab Consumption by Types from 2016 to 2027
-
Table Northeast China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Durvalumab Consumption Share by Types in 2016
-
Figure Northeast China Durvalumab Consumption Share by Types in 2021
-
Figure Northeast China Durvalumab Consumption Share by Types in 2027
-
Table Northeast China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table Northeast China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Durvalumab Consumption Share by End-Users in 2016
-
Figure Northeast China Durvalumab Consumption Share by End-Users in 2021
-
Figure Northeast China Durvalumab Consumption Share by End-Users in 2027
-
Table Southwest China Durvalumab Consumption by Types from 2016 to 2027
-
Table Southwest China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Durvalumab Consumption Share by Types in 2016
-
Figure Southwest China Durvalumab Consumption Share by Types in 2021
-
Figure Southwest China Durvalumab Consumption Share by Types in 2027
-
Table Southwest China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table Southwest China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Durvalumab Consumption Share by End-Users in 2016
-
Figure Southwest China Durvalumab Consumption Share by End-Users in 2021
-
Figure Southwest China Durvalumab Consumption Share by End-Users in 2027
-
Table Northwest China Durvalumab Consumption by Types from 2016 to 2027
-
Table Northwest China Durvalumab Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Durvalumab Consumption Share by Types in 2016
-
Figure Northwest China Durvalumab Consumption Share by Types in 2021
-
Figure Northwest China Durvalumab Consumption Share by Types in 2027
-
Table Northwest China Durvalumab Consumption by End-Users from 2016 to 2027
-
Table Northwest China Durvalumab Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Durvalumab Consumption Share by End-Users in 2016
-
Figure Northwest China Durvalumab Consumption Share by End-Users in 2021
-
Figure Northwest China Durvalumab Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Medimmune (AstraZeneca)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune (AstraZeneca)
-
Figure Sales and Growth Rate Analysis of Medimmune (AstraZeneca)
-
Figure Revenue and Market Share Analysis of Medimmune (AstraZeneca)
-
Table Product and Service Introduction of Medimmune (AstraZeneca)
-
